Search
Back

Rotigotine

CAS 92206-54-7
Rotigotine

General Information

Rotigotine API is a synthetic, non-selective dopamine agonist indicated for the treatment of Parkinson’s Disease and Restless Leg Syndrome in its finished dose. Its mechanism of action is through binding to and activating dopamine receptors in the brain, mimicking the effects of dopamine. Its transdermal patch formulation allows provide continuous delivery of the treatment over a specified timeframe 


About the API

Technology Synthetic
Therapeutic category Parkinson
Systematic Name (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.